Vironexis Biotherapeutics
Phase 2/3We aim to revolutionize the immunotherapy landscape and transform the treatment of cancer.
Founded
2021
Focus
RNA & Gene TherapyCell & Gene Therapy
About
We aim to revolutionize the immunotherapy landscape and transform the treatment of cancer.
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePhase 2/3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile